Description: A Pfizer-led group plans to buy access to hospital records in New York State to help identify and enroll participants in drug studies
Date: Nov 3, 2011
Pharmaceutical companies can easily spend years—and more than $1 billion—bringing a new drug to market, in part because they can’t find enough patients to do the required testing of the compound. Such delays can cost up to $1 million a day, fritter away valuable months of patent protection, and allow rival developers to catch up. One remedy: pay hospitals to sift through the health records of their patients. READ REST OF STORY
Questions for discussion:
- What are the ethical issues surrounding the data mining of health records?
- What limitations if any would you put in place to control the data-mining of health records?